Caballero, Baby Girl .
HRN: 22-41-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/31/2022
01/06/2023
IV
32mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes